Phio Pharmaceuticals Corp. (PHIO) Financials

PHIO Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 14.3 million 1.7 million
March 31, 2026 17.4 million 950000
Dec. 31, 2025 21.5 million 1.3 million
Sept. 30, 2025 11.5 million 1.7 million

PHIO Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -4.0 million 278000
March 31, 2026 -4.0 million 318000
Dec. 31, 2025 -2.1 million 274000
Sept. 30, 2025 -2.1 million 113000

PHIO Net Income

No data available :(

PHIO Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 13.0 million - -
March 31, 2026 17.0 million - -
Dec. 31, 2025 21.0 million - -
Sept. 30, 2025 10.7 million - -

PHIO Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 11.6 million
March 31, 2026 11.6 million
Dec. 31, 2025 11.6 million
Sept. 30, 2025 5.5 million

PHIO Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 - 3.1 million 1.2 million -
March 31, 2026 - 2.8 million 1.4 million -
Dec. 31, 2025 - 1.5 million 1.1 million -
Sept. 30, 2025 7000 1.2 million 1.3 million -

PHIO Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 - 1000
March 31, 2026 - 1000
Dec. 31, 2025 - 1.5 million
Sept. 30, 2025 - 1.2 million

PHIO

Price: $0.87

52 week price:
0.81
4.19

Earnings Per Share: -1.28 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 90800

Market Capitalization: 11.6 million

Links: